The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


VARIVAX powder and solvent for suspension for injection Varicella Vaccine (live)

Powder and solvent for suspension for injection

Merck Sharp & Dohme Ireland (Human Health) LimitedPA1286/057/001

Main Information

Trade NameVARIVAX powder and solvent for suspension for injection Varicella Vaccine (live)
Active SubstancesVaricella virus (oka strain) live attenuated
Strength
Dosage FormPowder and solvent for suspension for injection
Licence HolderMerck Sharp & Dohme Ireland (Human Health) Limited
Licence NumberPA1286/057/001

Group Information

ATC CodeJ07BK01 varicella, live attenuated

Status

Authorised/WithdrawnAuthorised
Licence Issued04/11/2003
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches of Human Albumin used in manufacture shall be subject to control authority batch release in accordance with Article 114.2 of Directive 2001/83/EC as amended. Batches of Vaccine marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC as amended.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back